Cutler Group LP Aravive, Inc. Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$2.19 - $4.07 $2,190 - $4,070
-1,000 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$3.67 - $5.8 $3,670 - $5,800
1,000 New
1,000 $1,000
Q1 2020

May 07, 2020
SELL
$3.5 - $13.77 $12,950 - $50,949
-3,700 Closed
0 $0
Q4 2019

Feb 06, 2020
BUY
$6.21 - $14.02 $22,977 - $51,874
3,700 New
3,700 $6,000

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email